Senior Medical Director, Clinical Development, Cardiovascular/Metabolism

Senior Medical Director, Clinical Development, Cardiovascular/Renal/MetabolismAt Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Senior Medical Director, Clinical Development to join our Cardiovascular/Renal/Metabolism team, supporting programs focused on obesity and related comorbidities. In this role, you will serve as Scientific and Medical Lead for clinical team(s), guiding development strategy and regulatory submissions while collaborating with Operational Leads, discovery teams, and Global Patient Safety. This role reports to an Executive Medical Director, Internal Medicine. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.When & where:Location: Tarrytown, NY, Cambridge, MA, or Warren, NJTravel: 10% to relevant conferencesDiscover your role:Develop innovative clinical strategies to shorten development cycles amid an evolving regulatory landscapeDesign efficient, robust Phase 2/3 programsPartner with discovery teams to inform next-generation targets and lead Phase 1 clinical testing plans for initial PK/PD and safety characterizationSafeguard patient safety in clinical studies and support signal detection from post-marketing surveillanceAct as medical expert and leader in interactions with external stakeholdersPlan and execute publication and clinical communication strategy, and contribute to key external presentationsEnsure the quality of clinical documents, including investigator brochures, protocols, study reports, and regulatory submission materialsThis role requires:MD or equivalent advanced medical degreeClinical training in Endocrinology or Cardiology (board certified or eligible) strongly preferredMinimum of 4 years of relevant clinical development experience in industry, including protocol design, study start-up, and study team executionExperience with regulatory filings and health authority interactions preferred